Folic acid-polysaccharide complex, its preparation method and pharmaceutical composition containing the same as active component
The present invention relates to folic acid-polysaccharide complexs and method of preparation thereof, more particularly relates to folic acid-Dextran complexs, method of preparation thereof, pharmaceutical compositions having said complex as active component and uses of said composition in therapy of tumors. The folic acid-polysaccharide complexs of the present invention have general formula of: (X) n —Y, wherein X is identical or different, and is selected from folic acid, derivatives of folic acid and other substances that can enter into cell via the pathway of folic acid receptor; Y is polysaccharide; n≧1.
1. A folic acid-polysaccharide complex, characterizing in that it has the following general formula: (X)n-Y, wherein X is identical or different, and is selected from the group consisting of folic acid, folinic acid, dihydrofolic acid, tetrahydrofolic acid, tetrahydropterin, pteroyl-polyglutamic acid, 2-deamino-hydroxy-folic acid, 1-denitrofolic acid, 3-denitrofolic acid, 8-denitrofolic acid; and Y is a polysaccharide other than arabinogalactan selected from glucans, dextrans, polysaccharoses, frustosans, heteropolysaccharides, mono- or heteropolysaccharide sulfates, mono- or heteropolysaccharide polysaccharides, ginseng pectin polysaccharide and other pectic polysaccharides, gummi tragacanthae, gumghatti, alginate, mono- or hetero-glycuronate-polysaccharides, polyethylene oxide, methoxypolyethylene glycol, and hydrophilic alcoholic polymers; and n≧1; wherein said folic acid-polysaccharide complex enters into cell via the pathway of the folic acid receptor on the cell membrane.
2. A folic acid-polysaccharide complex according to claim 1 , characterizing in that said polysaccharide Y is selected from the group consisting of glucans, polysaccharoses, fructosans, heteropolysaccharides, mono- or hetero-polysaccharide sulfates, mono- or hetero-glycuronate-polysaccharides and other hydrophilic alcoholic polymers.
3. A folic acid-polysaccharide complex according to claim 2 , characterizing in that said polysaccharide has the molecular weight range of 4,000 to 2,000,000.
4. A folic acid-polysaccharide complex according to claim 2 , characterizing in that said glucans is dextran.
5. A folic acid-polysaccharide complex according to claim 4 , characterizing in that said dextran has molecular weight range of 10,000 to 2,000,000.
6. A folic acid-polysaccharide complex according to claim 5 , characterizing in that said dextran has molecular weight range of 10,000 to 150,000.
7. A folic acid-polysaccharide complex according to claim 6 , characterizing in that said dextran has molecular weight of about 105,000.
8. A pharmaceutical composition useful in antineoplastics, characterizing in that it comprises folic acid-polysaccharide complex according to claim 1 and pharmaceutical acceptable adjuvants.
9. A pharmaceutical composition according to claim 8 , characterizing in that it is in form of a lyophilized powder, dry syrup or enteric capsule.
10. A method for the treatment of tumor cells, on the cell membranes of which exist over-expressed folic acid receptors, in a patient in need thereof comprising the step of administering to the patient the folic acid-polysaccharide complex of claim 1 .
11. A folic acid-polysaccharide complex according to claim 1 , characterizing in that said polysaccharide has the molecular weight range of 4,000 to 2,000,000.
12. A folic acid-polysaccharide complex, characterizing in that it has the following general formula: (X)n-Y, where X is folic acid, Y is dextran, and n≧1.
13. A folic acid-polysaccharide complex, characterizing in that it has the following general formula (X)n-Y, where X is folic acid, Y is ficoll, and n≧1.
14. A folic acid-polysaccharide complex, characterizing in that it has the following general formula (X)n-Y, where X is folic acid, Y is dextrin, and n≧1.
15. A folic acid-polysaccharide complex, characterizing in that it has the following general formula (X)n-Y, where X is folic acid, Y is heparin, and n≧1.
16. A folic acid-polysaccharide complex according to claim 1 , where X is dihydrofolic acid and Y is dextran.
17. A folic acid-polysaccharide complex according to claim 1 , where X is tetrahydrofolic acid and Y is dextran.